It s estimated that 1 in 8 people with COVID develop long COVID; of those patients, 44% also experience headaches. Research has found that many of those headaches are migraines.
Tonix Pharmaceuticals said on Tuesday its experimental drug failed to meet the primary goal in a midstage study for management of widespread muscle pain and tenderness associated with long COVID-19.
Millions of people with long COVID but no confirmed diagnosis were likely exposed to the virus and should be accepted in COVID clinics and research studies, researchers say.